Annual CFF:
-$58.30M-$19.31M(-49.53%)Summary
- As of today, ADMA annual cash from financing is -$58.30 million, with the most recent change of -$19.31 million (-49.53%) on December 31, 2024.
- During the last 3 years, ADMA annual cash from financing has fallen by -$179.35 million (-148.16%).
- ADMA annual cash from financing is now -140.52% below its all-time high of $143.90 million, reached on December 31, 2020.
Performance
ADMA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$48.00K+$7.17M(+100.67%)Summary
- As of today, ADMA quarterly cash from financing is $48.00 thousand, with the most recent change of +$7.17 million (+100.67%) on June 30, 2025.
- Over the past year, ADMA quarterly cash from financing has increased by +$410.00 thousand (+113.26%).
- ADMA quarterly cash from financing is now -99.95% below its all-time high of $101.20 million, reached on March 31, 2020.
Performance
ADMA Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$63.57M+$410.00K(+0.64%)Summary
- As of today, ADMA TTM cash from financing is -$63.57 million, with the most recent change of +$410.00 thousand (+0.64%) on June 30, 2025.
- Over the past year, ADMA TTM cash from financing has dropped by -$23.18 million (-57.40%).
- ADMA TTM cash from financing is now -135.91% below its all-time high of $177.03 million, reached on March 31, 2020.
Performance
ADMA TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ADMA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -49.5% | +113.3% | -57.4% |
| 3Y3 Years | -148.2% | +115.0% | -158.3% |
| 5Y5 Years | -172.9% | +2923.5% | -156.8% |
ADMA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -148.2% | at low | -99.9% | +100.1% | -158.4% | +4.1% |
| 5Y | 5-Year | -140.5% | at low | -99.9% | +100.1% | -144.2% | +4.1% |
| All-Time | All-Time | -140.5% | at low | -100.0% | +100.1% | -135.9% | +4.1% |
ADMA Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $48.00K(+100.7%) | -$63.57M(+0.6%) |
| Mar 2025 | - | -$7.13M(+77.0%) | -$63.98M(-9.7%) |
| Dec 2024 | -$58.30M(-49.5%) | -$31.03M(-21.8%) | -$58.30M(+12.0%) |
| Sep 2024 | - | -$25.47M(-6935.1%) | -$66.27M(-64.1%) |
| Jun 2024 | - | -$362.00K(+75.0%) | -$40.39M(-1.5%) |
| Mar 2024 | - | -$1.45M(+96.3%) | -$39.79M(-2.0%) |
| Dec 2023 | -$38.99M(-135.8%) | -$38.99M(-9487.1%) | -$38.99M(-162.1%) |
| Sep 2023 | - | $415.40K(+73.0%) | $62.75M(+2.0%) |
| Jun 2023 | - | $240.10K(+136.9%) | $61.49M(+0.9%) |
| Mar 2023 | - | -$650.50K(-101.0%) | $60.93M(-44.0%) |
| Dec 2022 | $108.85M(-10.1%) | $62.74M(+7535.8%) | $108.85M(+8.9%) |
| Sep 2022 | - | -$843.80K(-164.5%) | $99.93M(-8.3%) |
| Jun 2022 | - | -$319.00K(-100.7%) | $108.97M(-13.8%) |
| Mar 2022 | - | $47.27M(-12.2%) | $126.47M(+4.5%) |
| Dec 2021 | $121.05M(-15.9%) | $53.82M(+556.1%) | $121.05M(+21.9%) |
| Sep 2021 | - | $8.20M(-52.3%) | $99.29M(-2.4%) |
| Jun 2021 | - | $17.18M(-58.9%) | $101.72M(+20.3%) |
| Mar 2021 | - | $41.84M(+30.5%) | $84.54M(-41.3%) |
| Dec 2020 | $143.90M(+79.9%) | $32.06M(+201.6%) | $143.90M(+28.7%) |
| Sep 2020 | - | $10.63M(>+9900.0%) | $111.83M(+10.5%) |
| Jun 2020 | - | -$1700.00(-100.0%) | $101.19M(-42.8%) |
| Mar 2020 | - | $101.20M(>+9900.0%) | $177.03M(+121.3%) |
| Dec 2019 | $80.00M(+86.4%) | -$7700.00(-1.3%) | $80.00M(-0.0%) |
| Sep 2019 | - | -$7600.00(-100.0%) | $80.01M(+0.0%) |
| Jun 2019 | - | $75.84M(+1715.6%) | $80.00M(+69.9%) |
| Mar 2019 | - | $4.18M(>+9900.0%) | $47.10M(+9.7%) |
| Dec 2018 | $42.92M | -$500.00(+96.1%) | $42.92M(-54.0%) |
| Sep 2018 | - | -$12.90K(-100.0%) | $93.30M(+1.8%) |
| Jun 2018 | - | $42.94M(>+9900.0%) | $91.65M(+48.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$4400.00(-100.0%) | $61.86M(+1.8%) |
| Dec 2017 | $60.75M(+260.8%) | $50.37M(+3128.6%) | $60.75M(+485.7%) |
| Sep 2017 | - | -$1.66M(-112.6%) | $10.37M(-12.4%) |
| Jun 2017 | - | $13.15M(+1279.7%) | $11.84M(-24.7%) |
| Mar 2017 | - | -$1.12M(>-9900.0%) | $15.73M(-6.6%) |
| Dec 2016 | $16.84M(+61.9%) | -$3900.00(+98.0%) | $16.84M(+0.3%) |
| Sep 2016 | - | -$198.90K(-101.2%) | $16.78M(-0.4%) |
| Jun 2016 | - | $17.04M(>+9900.0%) | $16.85M(>+9900.0%) |
| Mar 2016 | - | -$3700.00(+93.8%) | -$61.40K(-100.6%) |
| Dec 2015 | $10.40M(+6.2%) | -$59.30K(+53.7%) | $10.40M(-32.9%) |
| Sep 2015 | - | -$128.10K(-198.8%) | $15.50M(-0.5%) |
| Jun 2015 | - | $129.70K(-98.8%) | $15.58M(+0.7%) |
| Mar 2015 | - | $10.46M(+107.6%) | $15.47M(+57.9%) |
| Dec 2014 | $9.80M(-64.6%) | $5.04M(>+9900.0%) | $9.80M(-68.8%) |
| Sep 2014 | - | -$49.10K(-399.4%) | $31.43M(-0.1%) |
| Jun 2014 | - | $16.40K(-99.7%) | $31.44M(-0.2%) |
| Mar 2014 | - | $4.79M(-82.0%) | $31.50M(+14.0%) |
| Dec 2013 | $27.63M(+41.9%) | $26.67M(>+9900.0%) | $27.63M(+498.0%) |
| Sep 2013 | - | -$31.40K(-145.7%) | $4.62M(+0.2%) |
| Jun 2013 | - | $68.70K(-92.6%) | $4.61M(+8.7%) |
| Mar 2013 | - | $925.70K(-74.7%) | $4.25M(-78.2%) |
| Dec 2012 | $19.47M(+1409.0%) | $3.66M(+9527.1%) | $19.47M(+23.1%) |
| Sep 2012 | - | -$38.80K(+87.0%) | $15.81M(-0.2%) |
| Jun 2012 | - | -$299.00K(-101.9%) | $15.85M(-1.9%) |
| Mar 2012 | - | $16.15M(>+9900.0%) | $16.15M(>+9900.0%) |
| Dec 2011 | $1.29M(-43.7%) | - | - |
| Mar 2011 | - | $17.00K(+100.0%) | $25.50K(+200.0%) |
| Dec 2010 | $2.29M(+9861.3%) | $8500.00(>+9900.0%) | $8500.00(>+9900.0%) |
| Sep 2010 | - | $0.00 | $0.00 |
| Jun 2010 | $23.00K | - | - |
FAQ
- What is ADMA Biologics, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. annual cash from financing year-on-year change?
- What is ADMA Biologics, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. quarterly cash from financing year-on-year change?
- What is ADMA Biologics, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. TTM cash from financing year-on-year change?
What is ADMA Biologics, Inc. annual cash from financing?
The current annual cash from financing of ADMA is -$58.30M
What is the all-time high annual cash from financing for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high annual cash from financing is $143.90M
What is ADMA Biologics, Inc. annual cash from financing year-on-year change?
Over the past year, ADMA annual cash from financing has changed by -$19.31M (-49.53%)
What is ADMA Biologics, Inc. quarterly cash from financing?
The current quarterly cash from financing of ADMA is $48.00K
What is the all-time high quarterly cash from financing for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high quarterly cash from financing is $101.20M
What is ADMA Biologics, Inc. quarterly cash from financing year-on-year change?
Over the past year, ADMA quarterly cash from financing has changed by +$410.00K (+113.26%)
What is ADMA Biologics, Inc. TTM cash from financing?
The current TTM cash from financing of ADMA is -$63.57M
What is the all-time high TTM cash from financing for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high TTM cash from financing is $177.03M
What is ADMA Biologics, Inc. TTM cash from financing year-on-year change?
Over the past year, ADMA TTM cash from financing has changed by -$23.18M (-57.40%)